These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4395463)

  • 1. Circulatory and electrocardiographic effects of oxprenolol in angina pectoris.
    Sharma B; Majid PA; Galvin MC; Taylor SH
    Postgrad Med J; 1970 Nov; ():Suppl:72-6. PubMed ID: 4395463
    [No Abstract]   [Full Text] [Related]  

  • 2. The action of intravenous oxprenolol, practolol, propranolol and sotalol on acute exercise tolerance in angina pectoris: the effect on heart rate and the electrocardiogram.
    Prichard BN; Aellig WH; Richardson GA
    Postgrad Med J; 1970 Nov; ():Suppl:77-85. PubMed ID: 4395464
    [No Abstract]   [Full Text] [Related]  

  • 3. Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.
    Arstila M; Iisalo E; Kallio V
    Ann Clin Res; 1969 May; 1(1):13-21. PubMed ID: 4390794
    [No Abstract]   [Full Text] [Related]  

  • 4. Haemodynamic effects of oxprenolol in hypertensive patients.
    Majid PA; Sharma B; Saxton C; Stoker JB; Taylor SH
    Postgrad Med J; 1970 Nov; ():Suppl:67-72. PubMed ID: 4395462
    [No Abstract]   [Full Text] [Related]  

  • 5. [Exercise tolerance in patients with angina pectoris with the beta blockader alprenol].
    Liljedal J
    Tidsskr Nor Laegeforen; 1971 Jul; 91(19):1451-8. PubMed ID: 4398226
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of a pure beta-blockador, 1-(4-nitrophenyl)-2-isopropylamino-ethanol in angina pectoris].
    Gasparotto G; Pagnan A
    Folia Cardiol; 1969; 28():40-3. PubMed ID: 4397999
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the symptomatic, electrocardiographic and haemodynamic effects of acute and long term -blockade in angina pectoris.
    Sharma B; Taylor SH
    Br J Pharmacol; 1971 Oct; 43(2):470P-471P. PubMed ID: 4400578
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of LB-46 in angina pectoris and cardiac arrhythmias].
    Maranhão MF; da Cunha GP; Rojas RI
    Arq Bras Cardiol; 1972 Feb; 25(1):51-60. PubMed ID: 4403346
    [No Abstract]   [Full Text] [Related]  

  • 9. [Coronary and left ventricular dynamics of three substances with different beta-blocking effects: Propranolol, Pindolol, and Practolol].
    Moccetti T; Halter J; Lichtlen P
    Schweiz Med Wochenschr; 1972 Mar; 102(12):422-5. PubMed ID: 4401753
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of angina pectoris and arrthymias with a beta receptor blockader].
    Willems D; Frisch P; Klepzig H
    Z Kreislaufforsch; 1971 Apr; 60(4):309-18. PubMed ID: 4397060
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of alprenolol on central hemodynamics and exercise tolerance in patients with angina pectoris.
    Jonsson B; Olsson AG; Orö L
    Cardiology; 1973; 58(3):152-61. PubMed ID: 4149331
    [No Abstract]   [Full Text] [Related]  

  • 12. A monitored release study. A clinical trial of oxprenolol in general practice.
    Forrest WA
    Practitioner; 1972 Mar; 208(245):412-6. PubMed ID: 4402044
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term clinical results of oxprenolol in the treatment of cardiac arrhythmias, angina pectoris and hypertrophic subaortic stenosis.
    Scebat L; Bensaid J
    Postgrad Med J; 1970 Nov; ():Suppl:86-90. PubMed ID: 4395465
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardio-selective beta-adrenergic inhibition by practolol in angina pectoris.
    Frick MH; Katila M
    Fortn Rev Chic Dent Soc; 1970 Sep; 60(5):96-101. PubMed ID: 4393719
    [No Abstract]   [Full Text] [Related]  

  • 15. The acute exercise test for the preliminary evaluation of beta-receptor blocking drugs in angina pectoris.
    Aellig WH; Prichard BN; Richardson GA
    Br J Pharmacol; 1969 Oct; 37(2):527P-528P. PubMed ID: 4390674
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxprenolol: clinical experiences with a new beta-adrenergic blocking drug.
    Bauer GE; Michell G
    Med J Aust; 1970 Jan; 1(4):170-3. PubMed ID: 4190852
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of beta-adrenergic blockage on the electrocardiographic exercise test in patients with angina pectoris].
    Lukasik S; Wrabec K; Nowosad H
    Pol Tyg Lek; 1972 Nov; 27(46):1796-9. PubMed ID: 4156081
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of adrenergic beta-blocking drugs in angina pectoris.
    Sharma B; Meeran MK; Galvin MC; Tulpule AT; Whitaker W; Taylor SH
    Br Med J; 1971 Jul; 3(5767):152-5. PubMed ID: 4397655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of alprenolol in the treatment of angina pectoris].
    Lippenholtz A; Talmasky S; Berconsky I
    Prensa Med Argent; 1969 Sep; 56(27):1357-61. PubMed ID: 4391256
    [No Abstract]   [Full Text] [Related]  

  • 20. [Arrhythmia action and cardiovascular effects of a new beta-adrenergic blockader (Oxprenolol)].
    Suzuki K; Kubota M; Odashiro M; Yasuda K; Goto Y
    Masui; 1972 Jan; 21(1):46-50. PubMed ID: 4401935
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.